Factors associated with the presence of tuberculosis in patients with acquired immunodeficiency syndrome in Cuba;Factores asociados con la presencia de tuberculosis en pacientes con el síndrome de inmunodeficiencia adquirida en Cuba

Revista Panamericana de Salud Publica/Pan American Journal of Public Health

Volumn 15, Issue 5, 2004, Pages 341-347

  Reyes Corcho, Andrés ^a,b   Díaz Jidy, Manuel ^c   Pérez Rodríguez, Antonio ^c   Bouza Jiménez, Yadira ^d   Bouza Jiménez, Yanelka ^a  

^a Hosp Univ Clin Q Dr GAL   (Cuba)

^b Inst de Med Trop Dr Pedro Kouri ^*  (Cuba)

^c INSTITUTO DE MEDICINA TROPICAL PEDRO KOURÍ   (Cuba)

^d HOSPITAL PEDIÁTRICO UNIVERSITARIO PAQUITO GONZÁLEZ CUETO   (Cuba)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; HEALTH MONITORING; RISK FACTOR; TUBERCULOSIS;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AIDS RELATED COMPLEX; ARTICLE; CANDIDIASIS; COCCIDIOSIS; CONTROLLED STUDY; CUBA; DISEASE ASSOCIATION; FEMALE; HEMOPTYSIS; HEPATOMEGALY; HOSPITAL DISCHARGE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; LUNG MYCOSIS; LYMPHADENOPATHY; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; NIGHT SWEAT; PNEUMONIA; PYREXIA IDIOPATHICA; SPLENOMEGALY; SYMPTOMATOLOGY; T LYMPHOCYTE; TOXOPLASMOSIS; TUBERCULOSIS; WEIGHT REDUCTION;

ADULT; CASE-CONTROL STUDIES; CUBA; FEMALE; HIV INFECTIONS; HUMANS; MALE; RETROSPECTIVE STUDIES; TUBERCULOSIS;

ATLANTIC ISLANDS; ATLANTIC OCEAN; CARIBBEAN ISLANDS; CUBA; GREATER ANTILLES;

EID: 3042766291     PISSN: 10204989     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Dye C, Scheele S, Dolin P, Pathania V, Raviglione M. Consensus statement: global burden of tuberculosis. Estimated incidence, prevalence, and mortality by country: WHO GLOBAL Surveillance and Monitoring Project. JAMA. 1999;282:677-86.
2. Small PM, Fujiwara PI. Medical progress: management of tuberculosis in the United States. N Engl J Med. 2001;345(3):189-200.
3. Division of Tuberculosis Elimination. Surveillance reports: reported tuberculosis in the United States, 2000. Atlanta: Centers for Disease Control and Prevention; 2001. Hallado en: http://www.cdc.gov/nchstp/tb/surv/surv2000/ default.htm. Acceso el 14 de abril. de 2004.
4. Santoro-Lopez G, Felix de Pinho AM, Harrison LH, Schechter M. Reduced risk of tuberculosis among Brazilian patients with advanced human immunodeficiency virus infection treated with highly active antiretroviral therapy. Clin Infect Dis. 2002;34:543-6.
5. Farmer P. The major disease in the world - to treat or not to treat? N Engl J Med. 2001; 345(3):208-10.
6. Armas Pérez L, González Ochoa E. Manejo de la tuberculosis en la República de Cuba. Rev Cubana Med Trop. 1998;50(2):150-8.
7. Van Cleeff MR, Chum HJ. The proportion of tuberculosis cases in Tanzania attributable to human immunodeficiency virus. Int J Epidemiol. 1995;24:637-42.
8. Geiter L. Ending neglect: the elimination of tuberculosis in the United States. Washington, D.C.: National Academy Press; 2000.
9. De Cock KM, Binkin NJ, Zuber PL, Tappero JW, Castro KG. Research issues involving HIV-associated tuberculosis in resource-poor countries. JAMA. 1996;276:1502-7.
10. Felix de Pinho AM, Santoro-Lopez G, Harrison LH, Schechter M. Chemoprophylaxis for tuberculosis and survival of HIV infected patients in Brazil. AIDS. 2001;15:2129-35.
11. Bentwich Z, Maartens G, Torten D, Lal AA, Lal RB. Concurrent infections and HIV pathogenesis. AIDS. 2000;14:2071-81.
12. Essex M. Human immunodeficiency viruses in the developing world. Adv Virus Res. 1999; 53:71-88.
13. Leonard MK, Larsen N, Drechsler H, Blumberg H, Lennox JL, Arrellano F, et al. Increased survival of persons with tuberculosis and human immunodeficiency virus infection, 1991-2000. Clin Infect Dis. 2002;43: 1002-7.
14. Collins KR, Quinones-Mateu ME, Toossi Z, Arts EJ. Impact of tuberculosis on HIV-1 replication, diversity, and disease progression. AIDS Rev. 2002;4(3):165-76.
15. Dean GL, Edwards SG, Ives NJ, Matthews G, Fox EF, Navaratne L, et al. Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy. AIDS. 2002;16:75-83.
16. Garcia de Olalla P, Martinez-Gonzalez MA, Cayla JA, Jansa JM, Iglesias B, Guerreo R, et al. Influence of highly active anti-retroviral therapy (HAART) on the natural history of extrapulmonary tuberculosis in HIV patients. Int J Tuberc Lung Dis. 2002;6(12):1051-7.
17. Hargreaves NJ, Kadzakumanja O, Whitty CJM, Salaniponi FML, Harries AD, Squire SB. Smear-negative pulmonary tuberculosis in DOTS programme: poor outcomes in an area of high HIV seroprevalence. Int J Tuberc Lung Dis. 2001;5(9):847-54.
18. Colebunders R, Bastian I. A review of the diagnosis and treatment of smear-negative pulmonary tuberculosis. Int J Tuberc Lung Dis. 2000;4(2):97-107.
19. Dotres Martínez C, Pérez González R, Santín Peña M, Marrero Figueroa A, eds. Programa Nacional de Control de la Tuberculosis. La Habana: Editorial Ciencias Médicas; 1999.
20. Díaz Jidy M, González Núñez I, Saladrigas Socarrás C, Pérez Ávila J, Millán Marcelo JC, Valdivia Álvarez JA. Coinfección HIV/TB en Cuba. Rev Cubana Med Trop. 1996;48(3): 214-7.
21. Torres R, Fiol J, Carreras L, Pérez J, Hernández O, Marrero A, Gil A, et al. La infección por el virus de la inmunodeficiencia humana y la tuberculosis en Cuba. Bol Oficina Sanit Panam. 1995;119(1):66-73.
22. Brauburger S. Clinical response to tuberculosis therapy in human immunodeficiency virus disease [tesis de maestría en Infectología y Enfermedades Tropicales]. La Habana: Instituto de Medicina Tropical Pedro Kourí; 1998.
23. Alfonso Hernández B. Comportamiento de la tuberculosis en los pacientes infectados por el virus de la inmunodeficiencia humana [tesis de maestría en Infectología y Enfermedades Tropicales]. La Habana: Instituto de Medicina Tropical Pedro Kourí, 1996.
24. Rojas Gómez LJ. Asociación entre la tuberculosis y el virus de la inmunodeficiencia humana en Cuba. Estudio clínico epidemiológico [tesis de maestría en Infectología y Enfermedades Tropicales]. La Habana: Instituto de Medicina Tropical Pedro Kourí, 1997.
25. a ed. Barcelona: Masson; 1997. Pp. 1689-97.
26. Fitzgerald DW, Desvarieux M, Severe P, Joseph P, Johnson WD, Pape JW. Effect of post-treatment isoniazid on prevention of recurrent tuberculosis in HIV-1 infected individuals: a randomised trial. Lancet. 2000;356: 1488-9.
27. Durack DT, Street AC. Fever of unknown origin reexamined and redefined. En: Remington JS, Swartz MN, eds. Current clinical topics in infections disease. Boston: Blackwell; 1991. Pp. 46-59.
28. Soriano E, Mallolas J, Gatell JM, Latorre X, Miró JM, Peccchiar M, et al. Characteristics of tuberculosis in HIV-infected patients. A case control study. AIDS. 1998;2:429-32.
29. Martin G, Lazarus A. Epidemiology and diagnosis of tuberculosis: recognition of at-risk patients is key to prompt detection. Postgrad Med. 2000;108(2):42-54.
30. El-Sohl A, Mylotte J, Sherif S, Serghani J, Grant BJ. Validity of a decision tree for predicting active pulmonary tuberculosis. Am J Respir Crit Care Med. 1997;155:1711-6.
31. De Castro Toledo AC, Greco DB, Antunes CM. Risk factors for tuberculosis among human immunodeficiency virus-infected persons. A case-control study in Belo Horizonte, Minas Gerais, Brazil (1985-1996). Mem Inst Oswaldo Cruz. 2000;95(4):437-43.
32. a ed. Madrid: Mc Graw Hill-Interamericana; 1998. Pp. 1149-61.
33. Jerant AF, Bannon M, Rittenhouse S. Identification and management of tuberculosis. Am Fam Physician. 2000;61:2667-82.
34. Baraia-Etxaburu J, Santamaría Jáuregui JM. Enfermedades causadas por micobacterias. En: Álvarez-Mon Soto M, Vera López E, Cano Ballesteros JC, eds. Enfermedades infecciosas. Madrid: IDEPSA; 1998. Pp. 399-404.
35. American Thoracic Society, Centers for Disease Control and Prevention. Diagnostic standards and classification of tuberculosis in adults and children. Am J Respir Crit Care Med. 2000;161:1376-95.